retatrutide 2025 trial results This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far beyond Weight loss with retatrutide as

What GLP-1 treatments work

A pesar de la baja incidencia de estos eventos adversos y de la probabilidad de que los beneficios superen estos riesgos en los individuos con obesidad grave, los mdicos y los pacientes deben ser conscientes de estos efectos secundarios graves

Weight loss medications and pregnancy are an underexplored area, but recent research and guidelines from drug manufacturers reveal some important facts about GLP-1 medications and pregnancy

In a clinical trial, adults who switched from high-dose injectable obesity drugs to oral GLP-1 pill Foundayo were able to maintain most of their previous weight loss over 1 year, with relatively limited weight regain

Rotating injection sites with each dose reduces their frequency and severity

Sjolund K, Sanden G, Hakanson R, Sundler F